Plasma-based COVID-19 treatments in low- and middle-income nations pose a high risk of an HIV epidemic

Leonardo M. R. FerreiraMohammed A. Mostajo-Radji2026-03-222026-03-22202010.1038/s41541-020-0209-2https://doi.org/10.1038/s41541-020-0209-2https://andeanlibrary.org/handle/123456789/45501Citaciones: 21enCoronavirus disease 2019 (COVID-19)Low and middle income countriesHuman immunodeficiency virus (HIV)PandemicMedicineVirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakDeveloping countryConvalescent plasmaPlasma-based COVID-19 treatments in low- and middle-income nations pose a high risk of an HIV epidemicarticle